Qiang Wang
Qiang Wang
Verified email at cshs.org
Title
Cited by
Cited by
Year
ErbB receptors: from oncogenes to targeted cancer therapies
H Zhang, A Berezov, Q Wang, G Zhang, J Drebin, R Murali, MI Greene
The Journal of clinical investigation 117 (8), 2051-2058, 2007
6472007
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
Q Wang, H Zhang, K Kajino, MI Greene
Oncogene 17 (15), 1939-1948, 1998
2931998
Rationally designed anti-HER2/neu peptide mimetic disables p185 HER2/neu tyrosine kinases in vitro and in vivo
BW Park, HT Zhang, C Wu, A Berezov, X Zhang, R Dua, Q Wang, G Kao, ...
Nature biotechnology 18 (2), 194-198, 2000
2392000
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors
CJ Wu, DM O'Rourke, GS Feng, GR Johnson, Q Wang, MI Greene
Oncogene 20 (42), 6018-6025, 2001
1562001
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14
JM Huang, I Nagatomo, E Suzuki, T Mizuno, T Kumagai, A Berezov, ...
Oncogene 32 (17), 2220-2229, 2013
1552013
TGF-β and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3
A Samanta, B Li, X Song, K Bembas, G Zhang, M Katsumata, SJ Saouaf, ...
Proceedings of the National Academy of Sciences 105 (37), 14023-14027, 2008
1512008
FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease
B Li, A Samanta, X Song, KT Iacono, P Brennan, TA Chatila, G Roncador, ...
International immunology 19 (7), 825-835, 2007
1512007
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
JA Freudenberg, Q Wang, M Katsumata, J Drebin, I Nagatomo, MI Greene
Experimental and molecular pathology 87 (1), 1-11, 2009
1432009
Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope
Z Zhou, X Du, Z Cai, X Song, H Zhang, T Mizuno, E Suzuki, MR Yee, ...
Journal of Biological Chemistry 287 (8), 5317-5326, 2012
1292012
BRCA1 and cell signaling
Q Wang, H Zhang, R Fishel, MI Greene
Oncogene 19 (53), 6152-6158, 2000
1092000
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma
S Inoda, Y Hirohashi, T Torigoe, M Nakatsugawa, K Kiriyama, ...
Journal of immunotherapy 32 (5), 474-485, 2009
1032009
FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer
B Han, Y Qu, Y Jin, Y Yu, N Deng, K Wawrowsky, X Zhang, N Li, S Bose, ...
Cell reports 13 (5), 1046-1058, 2015
962015
Structural insights into SUN-KASH complexes across the nuclear envelope
W Wang, Z Shi, S Jiao, C Chen, H Wang, G Liu, Q Wang, Y Zhao, ...
Cell research 22 (10), 1440-1452, 2012
962012
VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells
H Zhang, Q Wang, K Kajino, MI Greene
DNA and cell biology 19 (5), 253-263, 2000
852000
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function
X Song, B Li, Y Xiao, C Chen, Q Wang, Y Liu, A Berezov, C Xu, Y Gao, ...
Cell reports 1 (6), 665-675, 2012
832012
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1
Q Wang, H Zhang, S Guerrette, J Chen, A Mazurek, T Wilson, A Slupianek, ...
Oncogene 20 (34), 4640-4649, 2001
762001
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS
B Taylor-Harding, PJ Aspuria, H Agadjanian, DJ Cheon, T Mizuno, ...
Oncotarget 6 (2), 696, 2015
712015
Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis
S Morvaridi, D Dhall, MI Greene, SJ Pandol, Q Wang
Scientific reports 5, 16759, 2015
672015
Characterization of the structures involved in localization of the SUN proteins to the nuclear envelope and the centrosome
Q Wang, X Du, Z Cai, MI Greene
DNA and cell biology 25 (10), 554-562, 2006
662006
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma
S Inoda, R Morita, Y Hirohashi, T Torigoe, H Asanuma, E Nakazawa, ...
Experimental and molecular pathology 90 (1), 55-60, 2011
622011
The system can't perform the operation now. Try again later.
Articles 1–20